Rabeprazole extended-release 50 mg compared with esomeprazole 40 mg and rabeprazole delayed release 20 mg
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 2011
has subject area
- 1103 Clinical Sciences (FoR)
- 1115 Pharmacology and Pharmaceutical Sciences (FoR)
- 2-Pyridinylmethylsulfinylbenzimidazoles (MeSH)
- Anti-Ulcer Agents (MeSH)
- Delayed-Action Preparations (MeSH)
- Esomeprazole (MeSH)
- Female (MeSH)
- Gastroenterology & Hepatology (Science Metrix)
- Humans (MeSH)
- Male (MeSH)